James Murrough is a Psychiatry physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 282 publications with 22,760 citations (h-index 73); ClinicalTrials.gov lists 16 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Gustave L Levy Pl
Box 1230
New York, NY 100296500
Telephone
212-241-6383Registry record last updated 24 Feb 2009.
Clinical trials
- Neutralizing Interleukin (IL)-6
Sponsor: Icahn School of Medicine at Mount Sinai
- Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Sponsor: Icahn School of Medicine at Mount Sinai
- Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Sponsor: Icahn School of Medicine at Mount Sinai
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20252 payments
- Janssen Scientific Affairs, LLCProgram year20247 payments
- LivaNova USA, Inc.Program year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
11 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Neuroimmune Mechanisms of Depression and Anhedonia
Icahn School of Medicine at Mount Sinai
FY2026$839,815R01MH141038 - Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI
Icahn School of Medicine at Mount Sinai
FY2026$765,927R01MH134045 - Integrating Immune Dysregulation and Reward Circuitry in Veterans with Mood Disorders and Suicide"
James J Peters Va Medical Center
FY2026I01CX002787
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
New England Journal of Medicine
2023 - A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
American Journal of Psychiatry
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”